Paganelli R, Capobianchi M R, Ensoli B, D'Offizi G P, Facchini J, Dianzani F, Aiuti F
Department of Allergy & Clinical Immunology, University La Sapienza, Rome, Italy.
Clin Exp Immunol. 1988 Apr;72(1):124-9.
We have selected 11 patients with primary immunodeficiency disorders predominantly affecting T lymphocyte function (four with ataxia-telangiectasia (AT), four with common variable immunodeficiency (CVI) and one each with Wiskott-Aldrich syndrome, hyper-IgE syndrome and combined immunodeficiency) with defective gamma interferon (IFN-gamma) production in vitro. Induction with phytohaemagglutinin showed low interleukin 2 (IL-2) production concomitant with reduced IFN-gamma titres. However the addition of 10 U/ml of rIL-2 to cultures stimulated with staphylococcal enterotoxin B or galactose oxidase failed to restore IFN-gamma production in defective cases. IFN-gamma was titrated by both bioassay and immunoradiometric assay, ruling out the possible release of inactive or altered IFN-gamma molecules. Normal levels of IFN-gamma were found in patients of patients with AT, as well as in two AT and two CVI cases, demonstrating heterogeneity of defects within these syndromes. Soluble inhibitors or cellular suppression of IFN-gamma were not observed in mixing experiments. The possibility that defective interaction between accessory cells and T lymphocytes might account for the poor response to the inducing agents was ruled out as no IFN-gamma was produced using a calcium ionophore--which bypasses this step--in seven patients with absolute IFN-gamma deficiency.
我们选取了11例主要影响T淋巴细胞功能的原发性免疫缺陷病患者(4例共济失调毛细血管扩张症(AT)、4例普通可变型免疫缺陷病(CVI)、1例威斯科特-奥尔德里奇综合征、1例高IgE综合征和1例联合免疫缺陷病),这些患者体外γ干扰素(IFN-γ)产生存在缺陷。用植物血凝素诱导显示白细胞介素2(IL-2)产生较低,同时IFN-γ滴度降低。然而,向用葡萄球菌肠毒素B或半乳糖氧化酶刺激的培养物中添加10 U/ml的重组IL-2未能恢复缺陷病例中的IFN-γ产生。通过生物测定和免疫放射测定对IFN-γ进行滴定,排除了无活性或改变的IFN-γ分子可能释放的情况。在AT患者以及2例AT和2例CVI病例中发现了正常水平的IFN-γ,表明这些综合征内存在缺陷的异质性。在混合实验中未观察到IFN-γ的可溶性抑制剂或细胞抑制作用。辅助细胞与T淋巴细胞之间相互作用缺陷可能导致对诱导剂反应不佳的可能性被排除,因为在7例绝对IFN-γ缺乏的患者中,使用钙离子载体(绕过这一步骤)未产生IFN-γ。